Building trust with contract suppliers to overcome the challenges of manufacturing HPAPIs

摘要

High potency API (HPAPI) production is currently the fastest growing segment of the pharmaceutical market: the global market is predicted to double in value from approximately $9bn in 2011 to $18bn by 2018. The rising demand for drugs with increasing potencies is leading to a number of questions for manufacturing. This article reviews current trends and challenges for innovators and contract manufacturers involved in high potency production.